Respimat

Oct 16, 2019

Boehringer Ingelheim Announces First Patient Enrolled in Phase II Trial of Novel Cystic Fibrosis Treatment (BALANCE-CF(TM) 1)

Oct 11, 2018

FDA Approves Stiolto® Respimat® Supplemental New Drug Application (sNDA) to Add Data on COPD Exacerbation Reduction

Jul 23, 2018

Dry Powder Inhaler Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2026)

Apr 09, 2018

Pneuma Respiratory, Inc. Appoints Dr. Steven Kesten as President and Chief Medical Officer

Mar 29, 2018

New Large-Scale Trial Results Show Stiolto® Respimat® Prevents COPD Exacerbations Better Than Spiriva® Respimat®

Jan 10, 2018

Boehringer Ingelheim's Respimat Inhaler Awarded Arthritis Foundation's Ease of Use Commendation

Nov 02, 2017

Pneuma Respiratory develops first fully digital soft mist inhaler

Sep 19, 2017

New Documentary Film Shines Light on Physical and Emotional Impact of COPD